164 related articles for article (PubMed ID: 9839548)
1. Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats.
Fujiwara T; Ohsawa T; Takahashi S; Ikeda K; Okuno A; Ushiyama S; Matsuda K; Horikoshi H
Life Sci; 1998; 63(22):2039-47. PubMed ID: 9839548
[TBL] [Abstract][Full Text] [Related]
2. Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb.
Okuno A; Ikeda K; Shiota M; Fujiwara T; Yoshioka S; Sugano T; Horikoshi H
Metabolism; 1997 Jun; 46(6):716-21. PubMed ID: 9186311
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone has no effect on K(ATP) channel opener induced-relaxations in rat aorta and in human saphenous veins from patients with type 2 diabetes.
Yöntem O; Sahilli M; Karasu C; Ozçelikay AT; Altan VM; Ari N
Life Sci; 2000 Dec; 68(5):557-68. PubMed ID: 11197753
[TBL] [Abstract][Full Text] [Related]
4. Effect of troglitazone on exocrine pancreas in rats with streptozotocin-induced diabetes mellitus.
Shimizu K; Shiratori K; Hayashi N; Fujiwara T; Horikoshi H
Pancreas; 2000 Nov; 21(4):421-6. PubMed ID: 11075998
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone can prevent development of type 1 diabetes induced by multiple low-dose streptozotocin in mice.
Ogawa J; Takahashi S; Fujiwara T; Fukushige J; Hosokawa T; Izumi T; Kurakata S; Horikoshi H
Life Sci; 1999; 65(12):1287-96. PubMed ID: 10503944
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats.
Shimabukuro M; Higa S; Shinzato T; Nagamine F; Komiya I; Takasu N
Metabolism; 1996 Sep; 45(9):1168-73. PubMed ID: 8781306
[TBL] [Abstract][Full Text] [Related]
7. Differential block by troglitazone and rosiglitazone of glibenclamide-sensitive K(+) current in rat aorta myocytes.
Mishra SK; Aaronson PI
Eur J Pharmacol; 1999 Dec; 386(1):121-5. PubMed ID: 10611472
[TBL] [Abstract][Full Text] [Related]
8. Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats.
Santuré M; Pitre M; Nadeau A; Bachelard H
Metabolism; 2003 Aug; 52(8):978-86. PubMed ID: 12898461
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of troglitazone and nitric oxide on glucose uptake in L929 fibroblast cells.
Van Dyke DA; Walters L; Frieswyk D; Kokmeyer D; Louters LL
Life Sci; 2003 Apr; 72(21):2321-7. PubMed ID: 12639698
[TBL] [Abstract][Full Text] [Related]
10. Enhanced inhibition of L-type calcium currents by troglitazone in streptozotocin-induced diabetic rat cardiac ventricular myocytes.
Arikawa M; Takahashi N; Kira T; Hara M; Saikawa T; Sakata T
Br J Pharmacol; 2002 Jul; 136(6):803-10. PubMed ID: 12110604
[TBL] [Abstract][Full Text] [Related]
11. Effect of troglitazone, a new oral antidiabetic agent, on fructose-induced insulin resistance.
Yagi N; Takasu N; Higa S; Ishikawa K; Murakami K; Mimura G
Horm Metab Res; 1995 Oct; 27(10):439-41. PubMed ID: 8575720
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
[TBL] [Abstract][Full Text] [Related]
13. Acute troglitazone action in isolated perfused rat liver.
Preininger K; Stingl H; Englisch R; Fürnsinn C; Graf J; Waldhäusl W; Roden M
Br J Pharmacol; 1999 Jan; 126(1):372-8. PubMed ID: 10051158
[TBL] [Abstract][Full Text] [Related]
14. Synergistic actions of insulin and troglitazone on contractility in endothelium-denuded rat aortic rings.
Goud C; Pitt B; Webb RC; Richey JM
Am J Physiol; 1998 Nov; 275(5):E882-7. PubMed ID: 9815009
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
[TBL] [Abstract][Full Text] [Related]
16. Troglitazone (CS-045) ameliorates albuminuria in streptozotocin-induced diabetic rats.
Fujii M; Takemura R; Yamaguchi M; Hasegawa G; Shigeta H; Nakano K; Kondo M
Metabolism; 1997 Sep; 46(9):981-3. PubMed ID: 9284882
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone, an insulin sensitizer, increases forearm blood flow in humans.
Fujishima S; Ohya Y; Nakamura Y; Onaka U; Abe I; Fujishima M
Am J Hypertens; 1998 Sep; 11(9):1134-7. PubMed ID: 9752901
[TBL] [Abstract][Full Text] [Related]
18. Acute hemodynamic effects of insulin-sensitizing agents in isolated perfused rat hearts.
Uchida K; Ogino K; Shimoyama M; Hisatome I; Shigemasa C
Eur J Pharmacol; 2000 Jul; 400(1):113-9. PubMed ID: 10913592
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of hyperglycemia in streptozotocin-induced diabetic rats receiving a marginal mass of islet grafts by troglitazone, an oral antidiabetic agent.
Nagai T; Yasunami Y; Nagata N; Ryu S; Ono J; Ikeda S
Pancreas; 1996 Nov; 13(4):381-7. PubMed ID: 8899798
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K
Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
